Cardiovascular Diseases Clinical Trial
To identify the early emergence and stability of children's hostile behaviors and their associated psychophysiological responses to behavioral challenges, which are possible risk factors for cardiovascular diseases in adulthood; and to specify their determinants and consequences.
DESIGN NARRATIVE:
Beginning in 1980, the longitudinal study examined the Type A behavior pattern, hostility,
physiological responses and family interactive behaviors in primarily white, upper-middle
class children and parents. The study was renewed several times. In the fiscal year 1992
renewal, the research was extended to include the study of Black children and those from
lower-middle to middle class families. The inclusion of these groups is important not only
because these they have been understudied, but also because an examination is needed of
developmental factors that may be important in accounting for the much higher incidence of
hypertension and related disorders in Blacks and in lower and lower-middle class groups. The
current study examines the patterns of cardiovascular responses exhibited by Black and white
children in order to better assess hemodynamic and autonomic nervous system mechanisms that
underlie these responses. It also examines how these hemodynamic patterns relate to
cardiovascular risk factors such as body fat distribution, left ventricular geometry (via
echocardiography), as well as insulin, glucose, and lipid levels and it explores a new
conceptualization of hostility indices and cardiovascular risk factors.
A total of 184 Black and white children and adolescents of both genders are recruited for
participation, half being pre-pubescent (9-10 years old) and half being post-pubescent
(15-16 years old). The first laboratory session consists of a fasting venous blood draw,
collection of anthropomorphic data, a psychophysiological stress protocol involving four
tasks selected to elicit different autonomic nervous system responses, and completion of
standardized questionnaires to assess hostility and social support. A second session
involves an echocardiographic assessment of left ventricular geometry and cardiac
performance variables, the Type A Structured Interview, and an interview examining how
subjects process information about hostile intentions and actions of others.
The study has been extended through August 2007 to re-assess adolescents enrolled in Project
Pressure three years after their initial assessment to address key hypotheses regarding the
early emergence of behavioral risk factors for cardiovascular disease (CVD) in adolescence
and their antecedents and consequences. In the initial phase of Project Pressure, the
investigators collected data from 217 black and white, male and female high school students
to test cross-sectionally a model of the development of CVD risk factors. Their model
suggests that adolescents' socioeconomic status and ethnicity affect their exposure to
psychological stress, including discrimination, which, in turn, is thought to lead to the
development of the propensity to be vigilant for possible threat, to view ambiguous
situations as potentially harmful, and to mistrust others. These cognitive propensities may
become more automatic with development and lead to stable traits of hostility, anxiety, and
heightened cardiovascular responsivity to stress. These traits may then affect the early
development of vascular stiffness and left ventricular mass. They now propose to test the
model longitudinally using the same measures as in the initial assessment, plus adding some
new measures that take advantage of recent technological and conceptual advances: (a)
endothelial dysfunction and carotid intima medial thickness; (b) coping with discrimination
and ethnic identity; and (c) depression. They anticipate that 165 of the previous
adolescents will be reassessed, which is adequate in terms of power to test our key
hypotheses. The longitudinal design will be a stronger test of the model than the previous
cross-sectional study.
;
Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
| Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
| Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
| Completed |
NCT04056208 -
Pistachios Blood Sugar Control, Heart and Gut Health
|
Phase 2 | |
| Recruiting |
NCT04417387 -
The Genetics and Vascular Health Check Study (GENVASC) Aims to Help Determine Whether Gathering Genetic Information Can Improve the Prediction of Risk of Coronary Artery Disease (CAD)
|
||
| Not yet recruiting |
NCT06211361 -
Cardiac Rehabilitation Program in Patients With Cardiovascular Disease
|
N/A | |
| Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
| Recruiting |
NCT04514445 -
The BRAVE Study- The Identification of Genetic Variants Associated With Bicuspid Aortic Valve Using a Combination of Case-control and Family-based Approaches.
|
||
| Enrolling by invitation |
NCT04253054 -
Chinese Multi-provincial Cohort Study-Beijing Project
|
||
| Completed |
NCT03273972 -
INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
|
N/A | |
| Completed |
NCT03680638 -
The Effect of Antioxidants on Skin Blood Flow During Local Heating
|
Phase 1 | |
| Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
| Completed |
NCT04083846 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of High-dose CKD-385 in Healthy Volunteers(Fed)
|
Phase 1 | |
| Completed |
NCT04083872 -
Clinical Study to Investigate the Pharmacokinetic Profiles and Safety of Highdose CKD-385 in Healthy Volunteers(Fasting)
|
Phase 1 | |
| Completed |
NCT03466333 -
Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia
|
Phase 2 | |
| Completed |
NCT03619148 -
The Incidence of Respiratory Symptoms Associated With the Use of HFNO
|
N/A | |
| Completed |
NCT03693365 -
Fluid Responsiveness Tested by the Effective Pulmonary Blood Flow During a Positive End-expiratory Trial
|
||
| Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
| Completed |
NCT05132998 -
Impact of a Comprehensive Cardiac Rehabilitation Program Framework Among High Cardiovascular Risk Cancer Survivors
|
N/A | |
| Completed |
NCT05067114 -
Solutions for Atrial Fibrillation Edvocacy (SAFE)
|